Pfizer 'Bonus' Irks Judge In Bristol-Myers Cancer IP Dispute
A Massachusetts federal judge on Monday grilled Bristol-Myers Squibb Co. and Dana-Farber Cancer Institute over "troubling" settlement terms related to their prior high-profile patent ownership case that appeared to offer a...To view the full article, register now.
Already a subscriber? Click here to view full article